SHR-1314 injection

DRUG3 trials

Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Conditions

Active Non-radiographic Axial SpondyloarthritisPsoriatic Arthritis

Phase 2

Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis

CompletedNCT05055934

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Psoriatic Arthritis

Start: 2021-10-22End: 2024-06-05Updated: 2024-12-12

Phase 3

A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis

Active, not recruitingNCT06640257

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Psoriatic Arthritis

Start: 2024-11-04End: 2027-01-30Updated: 2026-08-06

A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis

RecruitingNCT06860750

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Active Non-radiographic Axial Spondyloarthritis

Start: 2025-04-29End: 2028-12-31Target: 380Updated: 2025-06-22